RANKL-induced c-Src activation contributes to conventional anti-cancer drug resistance and dasatinib overcomes this resistance in RANK-expressing multiple myeloma cells

Overview of attention for article published in Clinical and Experimental Medicine, October 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 14,847 followers.

RANKL-induced c-Src activation contributes to conventional anti-cancer drug resistance and dasatinib overcomes this resistance in RANK-expressing multiple #myeloma cells: https://t.co/3kjRGLhCOo. https://t.co/1moesboeCL

09 Oct 2018

Reply Repost Favourite